Atea Pharmaceuticals Holds Annual Meeting, Elects Directors
Ticker: AVIR · Form: 8-K · Filed: Jun 21, 2024 · CIK: 1593899
| Field | Detail |
|---|---|
| Company | Atea Pharmaceuticals, Inc. (AVIR) |
| Form Type | 8-K |
| Filed Date | Jun 21, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: annual-meeting, corporate-governance, auditor-ratification
TL;DR
Atea Pharma shareholders re-elected the board and kept PwC as auditor.
AI Summary
On June 21, 2024, Atea Pharmaceuticals, Inc. filed an 8-K report to announce the results of its 2024 Annual Meeting of Stockholders. The company reported that all director nominees were elected, and the appointment of PricewaterhouseCoopers LLP as its independent registered public accounting firm for the fiscal year ending December 31, 2024, was ratified.
Why It Matters
This filing confirms the company's leadership structure and auditor for the upcoming fiscal year, providing clarity for investors regarding corporate governance and financial oversight.
Risk Assessment
Risk Level: low — The filing is routine and reports on standard corporate governance matters like director elections and auditor ratification.
Key Players & Entities
- Atea Pharmaceuticals, Inc. (company) — Registrant
- PricewaterhouseCoopers LLP (company) — Independent registered public accounting firm
- June 21, 2024 (date) — Date of report
- December 31, 2024 (date) — Fiscal year end
FAQ
What was the primary purpose of the 8-K filing by Atea Pharmaceuticals, Inc. on June 21, 2024?
The primary purpose was to report the results of the company's 2024 Annual Meeting of Stockholders, including the election of directors and the ratification of its independent registered public accounting firm.
Were all director nominees elected at the Atea Pharmaceuticals, Inc. 2024 Annual Meeting?
Yes, the filing indicates that all director nominees presented at the meeting were elected.
Who was ratified as Atea Pharmaceuticals, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2024?
PricewaterhouseCoopers LLP was ratified as the independent registered public accounting firm.
What is Atea Pharmaceuticals, Inc.'s state of incorporation?
Atea Pharmaceuticals, Inc. is incorporated in Delaware.
What is the principal executive office address for Atea Pharmaceuticals, Inc.?
The principal executive offices are located at 225 Franklin Street, Boston, MA 02110.
Filing Stats: 580 words · 2 min read · ~2 pages · Grade level 11.5 · Accepted 2024-06-21 17:21:00
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 par value per share AVIR The Nasdaq
Filing Documents
- d891172d8k.htm (8-K) — 34KB
- 0001193125-24-165886.txt ( ) — 150KB
- avir-20240621.xsd (EX-101.SCH) — 3KB
- avir-20240621_lab.xml (EX-101.LAB) — 17KB
- avir-20240621_pre.xml (EX-101.PRE) — 11KB
- d891172d8k_htm.xml (XML) — 3KB
— Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers
Item 3 — Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers. FOR AGAINST ABSTAIN BROKER NON-VOTE 42,900,395 15,499,499 402,034 15,563,551 Based on the foregoing votes, Franklin Berger and Jean-Pierre Sommadossi were elected and Items 2 and 3 were approved.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ATEA PHARMACEUTICALS, INC. Date: June 21, 2024 By: /s/Andrea Corcoran Andrea Corcoran Chief Financial Officer and Executive Vice President, Legal and Secretary